SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 73,465 Value ($000) $2,407 Avg Close $26.13 Range $15.86 - $35.31

Q3 2024

Shares 227,950 Value ($000) $6,704 Avg Close $27.85 Range $23.00 - $32.41

Q2 2024

Shares 272,636 Value ($000) $6,410 Avg Close $33.73 Range $22.19 - $40.84

Q1 2024

Shares 32,397 Value ($000) $1,229 Avg Close $28.97 Range $18.54 - $47.97

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	73,465	$2,407	$26.13	$15.86 - $35.31
Q3 2024	227,950	$6,704	$27.85	$23.00 - $32.41
Q2 2024	272,636	$6,410	$33.73	$22.19 - $40.84
Q1 2024	32,397	$1,229	$28.97	$18.54 - $47.97